Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03820349 · ClinicalTrials.gov registry record
Cystic Fibrosis and Cognitive Function
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 28
- Enrollment target
NCT03820349: Completed study, sponsored by University of Minnesota.
NCT03820349 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03820349 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The long-term goal of this project is to examine the effects of cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD) on brain structure and function
Primary Outcome
Measure the differences in the microstructure (fractional anisotropy) of hippocampus, comparing subjects with cystic fibrosis and healthy controls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-12-10 |
What the finished NCT03820349 record still lists
NCT03820349 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03820349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03820349 about?
NCT03820349 is a clinical study titled "Cystic Fibrosis and Cognitive Function". The long-term goal of this project is to examine the effects of cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD) on brain structure and function
What is the current status of trial NCT03820349?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2018-05-07. Estimated completion is 2019-12-10.
Who is sponsoring clinical trial NCT03820349?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI